Company profile
True Health Medical-B / 真健康医疗-B
True Health Medical develops and commercializes percutaneous puncture and ablation surgical robots in China. Its TH-S robot family has NMPA Class III regis...
Facts
- Segment
- SURGICAL
- Country
- CN
- Headquarters
- Zhuhai, Guangdong
- Founded
- 2018
- Ticker
- 02697.HK
- Website
- https://www.truehealth.cn/
About True Health Medical-B / 真健康医疗-B
TH-S1 combines CT-image analysis, puncture-path planning, optical navigation, robotic positioning and respiratory tracking. The physician identifies the target and reviews the proposed trajectory, while the arm aligns the needle guide with the planned entry point and angle. Respiratory-phase monitoring helps coordinate insertion around motion of the chest or abdominal organs.
The wider product family includes TH-S, TH-S Pro and TH-SA variants for puncture and ablation workflows. True Health supplies the robot, planning software, clinical training and technical support to hospitals, while the clinician retains control of treatment decisions and needle execution. All four flagship variants hold Chinese Class III registrations, and the company began trading in Hong Kong on June 30, 2026.
Market context
DEPLOYMENT
Summary
Type: Surgical robotics
Core: TH-S puncture robots
Function: Puncture guidance
Audience: Hospitals